August 5, 2021, Plainview, N.Y. – Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced its partnership with CLX Health, developer of cloud-based solutions, and the TrustAssure™ platform, which is utilized by dozens of airlines globally, servicing over 75 countries worldwide. Acupath is part of a select group of...
Running a summer camp is very rewarding. That said, it’s also a worry-inducing, energy-draining, survive-each-day grind of ensuring each child is happy and healthy from the moment of arrival until the last high-five of the season. For better or worse, taking on the role of parent has always been the name of the job. And...
The pandemic forced many businesses to look at new ways of selling their goods and services. Certain pandemic-related changes may be temporary — for example, it remains to be seen how many companies will remain fully remote, James says. However, “businesses have already committed time and money resources towards pivots that involve identifying new target...
Lab to deliver fast and accurate results for those attending proms and graduation ceremonies June 3, 2021, Plainview, N.Y. – Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced it is providing COVID-19 PCR nasal swab testing for the Smithtown Central School District (SCSD) in collaboration with Well...
Partnership Aimed at Making COVID-19 Testing Easily Accessible for Patients Will Utilize Acupath’s Non-Invasive Saliva PCR Assay May 19, 2021, Plainview, N.Y. – Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced its partnership with Test Today USA, LLC, to provide mobile COVID-19 testing nationwide. Working together, Acupath and...
Benasource Selects Acupath Laboratories to Bring COVID-19 Saliva PCR Assay to Independent Pharmacies Across the Country
May 11, 2021by Acupath
PLAINVIEW, N.Y. , May 05, 2021 (GLOBE NEWSWIRE) — Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced it will provide COVID-19 saliva PCR testing for select independent pharmacies through Benasource, a leading group purchasing organization and provider of telemedicine solutions and digital pharmacy savings. By working together, Acupath...
Acupath Laboratories Announces Expansion of COVID-19 Test Offerings With Introduction of Low-Cost Saliva PCR Assay
April 14, 2021by Acupath
“Acupath Laboratories introduce Low-Cost Saliva PCR Assay. (Credit: PIRO4D from Pixabay.) Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced the availability of COVID-19 saliva PCR testing. Expanding COVID-19 testing options to include saliva provides organizations with an easier and faster alternative to the nasal swab PCR, which is...
Acupath Laboratories Announces Expansion of COVID-19 Test Offerings With Introduction of Low-Cost Saliva PCR Assay
April 13, 2021by Acupath
“New Option Presents an Affordable and Less Invasive Method for Schools and Businesses Requiring Frequent Testing for Employees and Students PLAINVIEW, N.Y., April 13, 2021 (GLOBE NEWSWIRE) — Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced the availability of COVID-19 saliva PCR testing. Expanding COVID-19 testing options to...
One year after perfecting the Pandemic Pivot, an innovative Plainview laboratory is doubling down on its unparalleled COVID-19 testing abilities – even as the vaccines flow. n fact, as more people are inoculated and governments on every level continue to ease COVID-related restrictions, testing for coronavirus mutations becomes even more important – and “it’s critical...
“Plainview, NY-based Acupath Laboratories, announced it will meet covid-19 PCR in-lab turnaround time (TAT) of 24 hours or less for all electronically ordering direct bill customers, or the test fee will be waived. This includes employers, school districts, the sports/entertainment industries, and others where testing is required. As testing remains necessary and becomes even more...
This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
*electronic orders for direct bill customers only, other terms and conditions may apply.
**insurance availability and copayment/coinsurance requirements are based on current government guidance and is subject to revision if/when plan/payor requirements evolve
The COVID-19 Pandemic is a rapidly evolving situation and guidance is updated frequently. Check your destination’s COVID-19 situation BEFORE traveling. Country, State, local, and territorial governments may have specific travel restrictions or requirements in place. It is ultimately the traveling individuals responsibility to confirm their destinations policy.
© 2024 Acupath Laboratories. All rights reserved